Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations. Hayashi H, Nadal E, Gray JE, Ardizzoni A, et al. Clin Lung Cancer 2022;23:e69-e82.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hayashi H, Nadal E, Gray JE, Ardizzoni A, et al. Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations. Clin Lung Cancer 2022;23:e69-e82.
PMID: 34865963